Research
Metabolic adaptation
Tirzepatide exhibited favorable effects on glycemic control, with reductions in HbA1c levels ranging from 20.4 mmol/mol with the 5 mg dose to 28.2 mmol/mol with the 15 mg dose.
Tirzepatide may improve glycemic control in patients with T2DM.
StrongSupportsmedium confidence
Tirzepatide exhibited favorable effects on glycemic control, with notable reductions in HbA1c levels ranging from 20.4 mmol/mol with the 5 mg dose to 28.2 mmol/mol with the 15 mg dose.
Why this rating
The claim is based on data from clinical trials with specific dosage effects.
Source
The promise of tirzepatide: A narrative review of metabolic benefits
Sara Sokary et al. · Primary care diabetes · 2025
reviewCited 24×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →